Leaflet NALBUPHINE SERB 20mg / 2ml solution for injection
Indicated for: moderate to severe pain
Route of administration: injectable
Substance: nalbuphine (opioid analgesic)
ATC: N02AF02 (Nervous system | Opioids | Morphinan derivatives)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
This medicine may cause dependence or be misused.
May slow breathing, especially with alcohol or sedatives.
Avoid alcohol during treatment.
This medicine may have important interactions with other medicines.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Older people may have an increased risk of side effects.
Do not stop treatment abruptly without medical advice.
This medicine may cause drowsiness or reduced alertness.
Nalbuphine is an opioid analgesic used for the treatment of moderate to severe pain. It works by binding to opioid receptors in the central nervous system, reducing the perception of pain.
The medication is administered via intramuscular, subcutaneous, or intravenous injection, with the dose adjusted based on the intensity of pain and the patient's response. Common side effects include nausea, dizziness, drowsiness, and excessive sweating.
Nalbuphine is contraindicated in patients with hypersensitivity to the active substance or other opioids. It should also be used with caution in patients with respiratory or hepatic impairment.
This medication is an effective option for managing acute pain, frequently used in postoperative or trauma settings.
General data about NALBUPHINE SERB 20mg / 2ml
- Substance: nalbuphine
- Date of latest medicines list: 01-04-2017
- Product code: W61418001
- Concentration: 20mg / 2ml
- Pharmaceutical form: solution for injection
- Quantity: 10
- Product type: Generic medicine
- Prescription status: TAB2 - Medicines dispensed with a special medical prescription for narcotic substances, yellow in color.